During the past decade, Jehangir Clinical Development Centre Pvt. Ltd. conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 23 clinical trials were completed, i.e. on average, 153.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 12 clinical trials were completed. i.e. 240% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jehangir Clinical Development Centre Pvt. Ltd." #1 sponsor was "Pfizer" with 11 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored and "Abbott Nutrition" with 3 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jehangir Clinical Development Centre Pvt. Ltd." #1 collaborator was "All India Institute of Medical Sciences, New Delhi" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Cancer Foundation of India" with 1 trials as a collaborator, "Cardiokine Biopharma, LLC" with 1 trials as a collaborator and "Christian Fellowship Community Health Centre" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Jehangir Clinical Development Centre Pvt. Ltd." are "Arthritis, Rheumatoid" (2 trials), "Breast Cancer" (2 trials), "Cardiovascular Disease" (2 trials), "Diabetes Mellitus, Type 2" (2 trials) and "Idiopathic Pulmonary Fibrosis" (2 trials). Many other conditions were trialed in "Jehangir Clinical Development Centre Pvt. Ltd." in a lesser frequency.

Most popular intervention types in "Jehangir Clinical Development Centre Pvt. Ltd." are "Drug" (30 trials), "Biological" (7 trials), "Other" (2 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Nintedanib" (3 trials), "CP-690,550" (2 trials), "Carboplatin" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Jehangir Clinical Development Centre Pvt. Ltd." are 32 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Jehangir Clinical Development Centre Pvt. Ltd.". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Jehangir Clinical Development Centre Pvt. Ltd., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Jehangir Clinical Development Centre Pvt. Ltd., 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".